Den europeiske union - norsk - EMA (European Medicines Agency)

janssen-cilag international n.v.    - ponesimod - multippel sklerose, relapsing-remitting - immunsuppressive - ponvory is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.